Last updated 2026-07-09
TL;DR
Childhood apraxia of speech (CAS) affects an estimated 1 to 2 children per 1,000. That's genuinely uncommon, but nowhere near vanishingly rare. Acquired apraxia in adults shows up more often, since stroke and brain injury are common causes of it. Both forms are probably underdiagnosed, and plenty of children spend years carrying the wrong label before anyone lands on the right one.
Apraxia of speech is a motor planning problem: the brain knows exactly what it wants to say but struggles to send the right movement instructions to the lips, tongue, and jaw. That's different from muscle weakness (dysarthria) or a language delay, and the distinction matters because the treatment differs too.
Prevalence isn't just trivia here. If a condition is extremely rare, your pediatrician may never have seen a case, which raises the odds of a delayed or wrong diagnosis. If it's more common than people assume, that's an argument for wider screening and faster referral to a specialist. The honest answer is that CAS sits in an awkward middle zone: rare enough that many general practitioners underestimate it, but common enough that most pediatric speech-language pathologists see it regularly. Knowing the actual numbers helps you advocate for your child. You can read a full clinical overview of the condition in our apraxia of speech article, and a dedicated look at the childhood form at childhood apraxia of speech.
How common is it in children?
Childhood apraxia of speech affects roughly 1 to 2 per 1,000 children, the most widely cited estimate [1]. Apraxia Kids (formerly the Childhood Apraxia of Speech Association of North America, CASANA) cites that same range, which works out to somewhere around 1 in 1,000 to 1 in 500 children in the general population [1].
That sounds small. For comparison, autism spectrum disorder now sits at about 1 in 36 children in the United States according to the CDC [2], so CAS is meaningfully rarer than ASD. But at 1 to 2 per 1,000, it's not an exotic diagnosis either: in a mid-size elementary school with 500 students, you'd statistically expect one child with CAS.
There's a real catch in that number, though. The research base is thin. A review published in the Journal of Speech, Language, and Hearing Research noted that rigorous population-based epidemiological data on CAS prevalence is essentially absent, and most estimates come from clinical samples or expert consensus rather than large community studies [3]. Estimates in the literature run from 0.1% to about 0.2% of the general population, consistent with the 1 to 2 per 1,000 figure, but the uncertainty is substantial.
Sex matters too. Boys are diagnosed with CAS at roughly two to three times the rate of girls, though nobody is sure how much of that reflects a true biological difference versus diagnostic bias [1].
How rare is it in adults?
Acquired apraxia of speech in adults is a different animal, and considerably less rare than the childhood form. The main cause is stroke. About 795,000 people in the United States have a stroke each year [4], and among stroke survivors with left hemisphere damage, acquired apraxia of speech shows up in roughly 10% to 15% of cases in some clinical series, though exact figures vary widely depending on how apraxia is defined and measured [5]. That means tens of thousands of new cases of acquired apraxia emerge in the US every year from stroke alone, before you even count traumatic brain injury, neurodegenerative disease, or brain tumors.
Primary progressive apraxia of speech (PPAOS) is a rarer adult form, where apraxia is the central feature of a slow neurodegenerative process. The Mayo Clinic has been a leading center for research on this condition, and its prevalence is estimated at somewhere between 3 and 4 per 100,000 in people over 60 [5], genuinely uncommon even within adult apraxia.
For adults recovering from stroke or brain injury, connecting with a speech-language pathologist quickly matters. Our overview of speech therapy for adults covers what to look for in a provider and what the research says about outcomes.
In absolute terms, far more adults live with apraxia of speech than children, simply because stroke is so common. But as a share of any one specific cause, whether that's neurodegenerative disease or childhood developmental disorders, the rates stay low.
Is it more common in children with autism?
Yes, substantially more common, and this is one of the more practically important facts for parents to know. The co-occurrence rate between CAS and autism spectrum disorder is estimated at around 36% to 65% across several studies, depending heavily on sample selection [6]. Research on minimally verbal autistic children has found CAS features at very high rates, suggesting the two conditions overlap far more than chance would predict [6].
ASHA (the American Speech-Language-Hearing Association) acknowledges the CAS-autism overlap directly in its clinical guidance, noting that differential diagnosis is hard because both conditions affect speech output and because some features of CAS can mask or mimic autism-related communication differences [7].
If your child has an autism diagnosis and is minimally verbal or has very inconsistent speech, it's worth asking a speech-language pathologist who knows CAS specifically whether a dual diagnosis applies. The treatment for CAS (high-frequency, motor-based practice with specific cueing) differs from general autism communication therapy, and getting the right approach sooner matters. Our article on autism spectrum speech therapy covers how SLPs approach assessment and treatment when both diagnoses may be in play.
Why does it go undiagnosed so often?
A few real structural problems push the diagnosed prevalence below the true prevalence. For one, CAS requires a speech-language pathologist to diagnose it, and access to SLPs is uneven: rural areas, lower-income communities, and communities of color all have documented gaps in access to pediatric SLP services [8]. Children who never see a specialist can't get a specialist diagnosis.
The symptoms also just look like an ordinary speech delay in young children. A 2-year-old with limited words and inconsistent sounds isn't obviously different from many late talkers, and most pediatricians don't have specialized training to spot CAS features. According to Apraxia Kids survey data, the average diagnostic delay is around 2 years from first parental concern to confirmed CAS diagnosis [1], two years of potentially wrong or absent intervention.
On top of that, CAS has no biomarker or objective test. Diagnosis depends on clinical observation of specific speech characteristics, mainly inconsistency in speech errors, prosodic abnormalities, and difficulty sequencing longer or more complex words and phrases. ASHA's practice portal notes that "diagnosis of CAS is based on observation of specific speech characteristics, and there is no single behavioral sign that is pathognomonic for the disorder" [7]. Clinicians without CAS-specific training can miss it or label it as something else. Children from bilingual or multilingual households are sometimes flagged as having a language difference rather than a disorder, which can delay evaluation further [8].
If you suspect something more than a standard speech delay, pushing for an evaluation by an SLP with specific CAS experience is reasonable and worth the effort. Early intervention services available before age 3 through IDEA Part C can connect you with evaluators without requiring a pediatrician referral in most states.
What causes it?
For most children diagnosed with CAS, the cause is unknown; clinicians call this idiopathic CAS. A smaller subset has an identifiable cause, falling into three main categories: neurological conditions affecting the motor cortex or related circuits, genetic syndromes, and brain injury (including stroke in utero or at birth).
The genetic connection is real. Mutations in the FOXP2 gene, sometimes called the "language gene," were first identified in a family with a high rate of speech and language disorders including CAS, in a 2001 Nature paper by Lai and colleagues [9]. But FOXP2 variants explain only a small minority of CAS cases. Researchers have since identified other genetic contributors, including variants in CNTNAP2 and several copy number variants associated with autism that also carry elevated CAS risk [6].
Galactosemia, a metabolic disorder detected on newborn screening, is associated with CAS at notably higher rates than the general population, suggesting metabolic pathways can affect speech motor development too [1].
None of this changes much for parents in practice: not having an identified cause is common and doesn't change the treatment approach. The motor planning deficit is real regardless of where it came from.
How is childhood apraxia of speech diagnosed?
There's no single test for CAS. A speech-language pathologist makes the diagnosis through a structured assessment that looks for specific patterns across several areas of a child's speech.
ASHA identifies three main diagnostic features: inconsistent errors on consonants and vowels across repeated attempts at the same syllables or words, lengthened and disrupted transitions between sounds, and off prosody, especially with stress patterns in words and phrases [7]. A child doesn't need to show all three. Very young or minimally verbal children are especially hard to assess, simply because they may not produce enough speech for a clinician to spot these patterns.
Clinicians commonly use tools like the Nuffield Dyspraxia Programme assessments, the Kaufman Speech Praxis Test, and the GFTA-3 (Goldman-Fristoe Test of Articulation), though none of these were built specifically to diagnose CAS. Dynamic Motor Speech Assessment, where the clinician watches how a child responds to cues during speech tasks, tends to reveal more than static standardized tests on their own.
For children who are nonverbal or minimally verbal, some clinicians run a diagnostic therapy trial instead: apply CAS-specific treatment techniques and watch whether the child responds in ways that point to a motor planning deficit. It's an imperfect method, but sometimes it's the most practical way forward.
If you're in the middle of this process, our piece on finding the right speech therapist walks through how to vet an SLP for CAS-specific training and what to ask before you commit to a provider.
How common is CAS compared to other childhood speech disorders?
Put CAS next to other speech and language conditions and its rarity becomes obvious. It's one of the least common communication diagnoses a child can receive.
| Condition | Estimated prevalence in children | Primary source |
|---|---|---|
| Speech sound disorders (any) | ~11 to 16% | ASHA practice portal [7] |
| Language disorder | ~7 to 8% | Norbury et al., 2016 |
| Stuttering | ~5% in preschool age, ~1% overall | NIDCD [10] |
| Autism spectrum disorder | ~2.8% (1 in 36) | CDC ADDM 2023 [2] |
| Selective mutism | ~0.7 to 1% | Clinical estimates |
| Childhood apraxia of speech | ~0.1 to 0.2% (1 to 2 per 1,000) | Shriberg et al. [3] |
CAS is rare next to speech sound disorders as a category (which includes things like lisps and phonological errors most kids outgrow on their own), and it's notably rarer than autism or stuttering. But it's not so rare that a pediatric SLP would be caught off guard by it, and it's common enough to justify advocacy organizations, insurance parity fights, and dedicated clinical training programs.
One wrinkle worth knowing: CAS can show up alongside other speech sound disorders, which muddies the prevalence numbers. A child with a phonological disorder and co-occurring CAS might get only the phonological diagnosis, or get it first.
What does treatment look like, and does starting early matter?
Treatment matters, and so does timing.
The core of CAS treatment is intensive, repetitive, motor-based practice paired with specific cueing. The most researched approaches include the Nuffield Dyspraxia Programme (NDP3), Dynamic Temporal and Tactile Cueing (DTTC), Rapid Syllable Transition Treatment (ReST), and PROMPT (Prompts for Restructuring Oral Muscular Phonetic Targets). None of these are a matter of playing with your child and hoping speech follows. They're structured and systematic, and they need a trained clinician to deliver them properly.
Systematic reviews have found that motor-based treatments beat general language stimulation for CAS outcomes, though the evidence base stays fairly small since the condition is rare and hard to study at scale [5]. ASHA's practice portal points the same direction: treatment decisions should be driven by motor-learning principles like high practice variability, immediate feedback, and systematic cueing [7].
Frequency matters too. Most clinical consensus holds that children with CAS need therapy at least two to three times a week, sometimes more during intensive stretches. That's more sessions than typical school-based caseloads often allow, which is a real gap families should know about going in.
For families juggling CAS alongside autism or other communication needs, AAC (augmentative and alternative communication) tools can bridge the gap during intensive motor work. Our article on AAC devices covers the options in detail.
For practice at home, the Little Words app gives parents structured, SLP-informed activities to run between sessions. It won't replace a therapist, but it can meaningfully boost the amount of repetition that motor learning depends on. If you're not sure where to start, take the quiz at Little Words to find activities matched to your child's current skill level.
Can kids with apraxia catch up to their peers?
Many do, and this is one of the more encouraging findings in the CAS research.
With early, targeted, intensive therapy, a good share of children with CAS go on to develop intelligible speech and functional communication. Kids who get appropriate treatment early, broadly before age 5 or 6, tend to have better long-term outcomes than those who start later, which lines up with what we know about motor learning and neural plasticity in general [3].
Some honesty is warranted too. Some children with CAS carry residual speech differences into adulthood, particularly with longer or more complex words. Literacy difficulties also show up more often in children with CAS than in the general population, likely because phonological awareness and speech production are so closely linked [1]. Worth keeping reading support on your radar alongside speech therapy.
Children with CAS plus a co-occurring condition like autism, intellectual disability, or a genetic syndrome tend to have a more complicated path. CAS itself still responds to the same motor-based approaches, but the overall communication picture gets harder and usually calls for a multidisciplinary team.
None of this is false hope. With appropriate treatment, the outlook for CAS is genuinely better than what many families fear when they first hear the diagnosis.
What should parents do if they suspect apraxia?
Start with a referral. Your pediatrician can refer you to a speech-language pathologist for evaluation, and in most US states you can also self-refer for an early intervention evaluation under IDEA Part C if your child is under 3 [8].
When you're looking for an SLP, ask directly whether they have experience with CAS and whether they use motor-based treatment. Not every SLP has this training, and general speech therapy without CAS-specific methods can waste months of valuable time.
Bring documentation to the evaluation. A short video of your child attempting words or phrases, especially one that shows inconsistent errors or visible effort on longer words, often tells an evaluator more than a description alone.
If the first evaluation doesn't come back with a CAS diagnosis but your gut says something motor-based is going on, getting a second opinion from a CAS specialist is reasonable. CAS is underdiagnosed, and because the treatment stakes are real, this is one of those situations where a parent pushing for answers genuinely changes outcomes.
For families with a child who is also autistic or has limited verbal output, online options can sometimes be more accessible than local providers. Online speech therapy has expanded quite a bit and now includes SLPs with CAS specialization.
You can also find a directory of ASHA-certified SLPs at the ASHA website [7], and Apraxia Kids keeps its own directory specifically for CAS-trained clinicians [1].
Frequently asked questions
How many children in the US have childhood apraxia of speech?
Using the 1 to 2 per 1,000 prevalence estimate against a US child population of roughly 73 million under age 18, you land somewhere between 73,000 and 146,000 children with CAS. The real number could be higher, since the condition is probably underdiagnosed. Treat these as rough estimates rather than a hard count: there's no large population registry tracking CAS.
Is apraxia of speech a form of autism?
No. Apraxia of speech is a motor planning disorder, while autism is a neurodevelopmental condition that affects social communication, behavior, and sensory processing. They're separate diagnoses, but they show up together far more often than chance would explain: some studies put the overlap at 36% to 65% among minimally verbal autistic children. A child can have one, both, or neither.
What is the difference between CAS and a speech delay?
A speech delay means a child is picking up sounds and words more slowly than peers, but on the same general path. CAS looks different: errors are inconsistent, longer words get tangled in sequencing, and prosody sounds off no matter how much the child practices. Since treatment approaches differ between the two, sorting out which one you're dealing with matters more than the label itself.
How rare is primary progressive apraxia of speech in adults?
Primary progressive apraxia of speech (PPAOS) shows up in roughly 3 to 4 per 100,000 adults over 60. It's a neurodegenerative condition where apraxia is the main feature, separate from the apraxia that follows a stroke. Because it's rare and progresses slowly, doctors often mistake it at first for another form of dementia or a language disorder.
Can a child with apraxia of speech ever speak normally?
Many children with CAS go on to develop speech that's clear and functional once they get appropriate treatment, and those who start motor-based therapy early tend to do better. Some carry residual differences into adulthood, particularly with complex words or under stress, and conditions that co-occur with CAS can shape the outcome too. There's no guarantee, but the prognosis tends to be better than families expect when they first get the diagnosis.
Is apraxia of speech hereditary?
Some cases have a genetic component. A 2001 Nature study linked FOXP2 mutations to a family with high rates of speech and language disorder, including CAS, and other variants have turned up since then. Most idiopathic CAS cases don't have a clear genetic cause, but a family history of speech or language problems does seem to raise the risk.
How do doctors test for apraxia of speech in children?
No blood test or brain scan diagnoses CAS. A speech-language pathologist makes the call through clinical observation, watching for inconsistent errors, rough transitions between sounds, and prosody that doesn't sound right. Tools like the GFTA-3 or KSPT bring some structure to the process, but experienced clinical judgment still drives the diagnosis. Dynamic Motor Speech Assessment, where the SLP watches how a child responds to cueing, often reveals the most.
Does insurance cover speech therapy for apraxia of speech?
Most major insurance plans cover speech therapy when it's medically necessary, and CAS typically clears that bar. What you actually pay depends on your plan, your state's insurance mandates, and whether the provider is in-network. For children under 3, early intervention is federally guaranteed through IDEA Part C and is often available free or on a sliding scale no matter your insurance situation.
What speech therapy approach works best for childhood apraxia of speech?
Motor-learning-based approaches have the strongest evidence behind them, among them Dynamic Temporal and Tactile Cueing (DTTC), the Nuffield Dyspraxia Programme (NDP3), Rapid Syllable Transition Treatment (ReST), and PROMPT. ASHA recommends building treatment around motor-learning principles: lots of repetition, systematic cueing, and feedback. General language stimulation on its own doesn't cut it for CAS, and leaning on it alone can cost a child months of progress.
Is apraxia of speech the same as dysarthria?
No. Dysarthria comes from muscle weakness or poor coordination, so it affects the strength and tone of the speech muscles themselves. Apraxia of speech is different: the muscles work fine, but the brain has trouble sequencing and timing the movements needed for speech. Both make speech harder to understand, but the error patterns and treatments aren't the same.
Can you develop apraxia of speech from a stroke?
Yes. A stroke affecting the left hemisphere, especially areas involved in motor speech planning, is the most common cause of acquired apraxia of speech in adults. Clinical estimates suggest roughly 10% to 15% of left-hemisphere stroke survivors develop it. It frequently shows up alongside aphasia, which complicates both diagnosis and treatment planning.
At what age is apraxia of speech usually diagnosed?
Most diagnoses land between ages 3 and 5, though parents often notice something's off as early as 18 months to 2 years. According to Apraxia Kids survey data, the average gap between that first parental concern and a confirmed diagnosis is about 2 years. Diagnosis before age 3 is tricky because young children often haven't produced enough speech yet for clinicians to spot the characteristic patterns.
How is childhood apraxia of speech different from selective mutism?
Selective mutism is rooted in anxiety: children can speak just fine in some settings but go quiet in others, and their speech motor system works normally throughout. CAS doesn't care about setting or anxiety level. It shows up as effortful, inconsistent errors even when a child is relaxed and wants to talk, whereas a child with selective mutism speaks fluently once they're comfortable.
Sources
- Apraxia Kids (formerly CASANA), CAS Prevalence and Facts page: CAS affects approximately 1 to 2 per 1,000 children; boys are diagnosed at roughly 2 to 3 times the rate of girls; average diagnostic delay is approximately 2 years; galactosemia is associated with elevated CAS rates
- CDC Autism and Developmental Disabilities Monitoring (ADDM) Network, 2023 Report: Autism spectrum disorder prevalence is approximately 1 in 36 children (about 2.8%) in the United States
- Shriberg LD, Aram DM, Kwiatkowski J. Developmental apraxia of speech: I. Descriptive and theoretical perspectives. Journal of Speech, Language, and Hearing Research. 1997;40(2):273-285. (and subsequent 2011 prevalence review by Shriberg et al., JSLHR): Population-based epidemiological data on CAS is essentially absent; prevalence estimates range from 0.1% to 0.2% of the general population based on available clinical sample data
- CDC, Stroke Facts: Approximately 795,000 people in the United States have a stroke each year
- Duffy JR. Motor Speech Disorders: Substrates, Differential Diagnosis, and Management. 3rd ed. Elsevier; 2013. (and Mayo Clinic PPAOS research, including Josephs et al., Brain, 2012): Among stroke survivors with left hemisphere damage, acquired apraxia occurs in roughly 10-15% of clinical cases; primary progressive apraxia of speech prevalence estimated at 3-4 per 100,000 in adults over 60; motor-based treatments produce better CAS outcomes than general language stimulation
- Tierney C et al. How valid is the checklist for autism spectrum disorder when a child has apraxia of speech? Journal of Developmental and Behavioral Pediatrics. 2015;36(8):569-574; and related CAS-ASD co-occurrence research: Co-occurrence rate between CAS and autism spectrum disorder is estimated at approximately 36% to 65% across studies; genetic variants including CNTNAP2 and autism-associated copy number variants carry elevated CAS risk
- American Speech-Language-Hearing Association (ASHA), Childhood Apraxia of Speech Practice Portal: ASHA identifies three primary diagnostic features of CAS: inconsistent errors on consonants and vowels, lengthened and disrupted coarticulatory transitions, and inappropriate prosody; diagnosis is based on observation and 'there is no single behavioral sign that is pathognomonic for the disorder'; motor-learning principles should drive treatment; speech sound disorders affect approximately 11-16% of children
- U.S. Department of Education, IDEA Individuals with Disabilities Education Act, Part C: Early intervention services under IDEA Part C are federally guaranteed for children under 3; families can self-refer for evaluation in most states without a physician referral; access gaps in rural and lower-income communities affect diagnostic rates
- Lai CS et al. A forkhead-domain gene is mutated in a severe speech and language disorder. Nature. 2001;413(6855):519-523.: FOXP2 gene mutations were identified in a family with a high rate of speech and language disorders including CAS features, establishing the first genetic link to an inherited severe speech and language disorder
- National Institute on Deafness and Other Communication Disorders (NIDCD), Stuttering fact sheet: Stuttering affects approximately 5% of children during the preschool years and approximately 1% of the overall population